WallStreetZenWallStreetZen

NASDAQ: CRBU
Caribou Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CRBU past revenue growth

How has CRBU's revenue growth performed historically?
Company
148.91%
Industry
148.64%
Market
17.33%
CRBU's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CRBU's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CRBU's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CRBU earnings and revenue history

Current Revenue
$34.5M
Current Earnings
-$102.1M
Current Profit Margin
-296.1%

CRBU Return on Equity

Current Company
-31.1%
Current Industry
-63.5%
Current Market
188%
CRBU's Return on Equity (-31.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRBU announces earnings.

CRBU Return on Assets

Current Company
-25.7%
Current Industry
2.9%
CRBU is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRBU Return on Capital Employed

Current Company
-25.22%
Current Industry
19.5%
CRBU has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRBU vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRBU$34.48M-$96.30M-$102.07M+56.22%N/A
AURA$0.00-$73.14M-$76.41MN/AN/A
FBLG$0.00-$15.90M-$19.06MN/AN/A
MNMD$0.00-$92.57M-$95.73MN/AN/A
TNYA$0.00-$112.27M-$124.08MN/AN/A
View Top Biotech Stocks

CRBU earnings dates

Next earnings date
May 7, 2024

Caribou Biosciences Earnings & Revenue FAQ

What were CRBU's earnings last quarter?

On Invalid Date, Caribou Biosciences (NASDAQ: CRBU) reported Q4 2023 earnings per share (EPS) of -$0.40, up 11.11% year over year. Total Caribou Biosciences earnings for the quarter were -$34.51 million. In the same quarter last year, Caribou Biosciences's earnings per share (EPS) was -$0.45.

If you're new to stock investing, here's how to buy Caribou Biosciences stock.

What was CRBU's earnings growth in the past year?

As of Q2 2024, Caribou Biosciences's earnings has grown year over year. Caribou Biosciences's earnings in the past year totalled -$102.07 million.

What is CRBU's earnings date?

Caribou Biosciences's earnings date is Invalid Date. Add CRBU to your watchlist to be reminded of CRBU's next earnings announcement.

What was CRBU's revenue last quarter?

On Invalid Date, Caribou Biosciences (NASDAQ: CRBU) reported Q4 2023 revenue of $3.56 million up 3.63% year over year. In the same quarter last year, Caribou Biosciences's revenue was $3.69 million.

What was CRBU's revenue growth in the past year?

As of Q2 2024, Caribou Biosciences's revenue has grown 148.91% year over year. This is 0.28 percentage points higher than the US Biotechnology industry revenue growth rate of 148.64%. Caribou Biosciences's revenue in the past year totalled $34.48 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.